Interstitial fibrosis, functional status, and outcomes in heart failure with preserved ejection fraction

Circulation: Cardiovascular Imaging

Volumn 9, Issue 12, 2016, Pages

  Duca, Franz ^a   Kammerlander, Andreas A ^a   Zotter Tufaro, Caroline ^a   Aschauer, Stefan ^a   Schwaiger, Marianne L ^a   Marzluf, Beatrice A ^b   Bonderman, Diana ^a   Mascherbauer, Julia ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b OTTO WAGNER HOSPITAL   (Austria)

Author keywords

heart failure; magnetic resonance imaging; mapping

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; FIBROSING ALVEOLITIS; FUNCTIONAL STATUS; HEART DEATH; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART RIGHT ATRIUM PRESSURE; HEART STROKE VOLUME; HEMODYNAMIC PARAMETERS; HOSPITALIZATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIX MINUTE WALK TEST; TISSUE DOPPLER IMAGING; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 85007043468     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.116.005277     Document Type: Article

References (38)

1. Hogg K, Swedberg K, McMurray J, Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 2004 43 317 327. doi: 10.1016/j.jacc.2003.07.046.
2. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P, Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology; ESC Committee for Practice Guidelines ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012 14 803 869. doi: 10.1093/eurjhf/hfs105.
3. Paulus WJ, Tschöpe C, A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 2013 62 263 271. doi: 10.1016/j.jacc.2013.02.092.
4. Martos R, Baugh J, Ledwidge M, O'Loughlin C, Conlon C, Patle A, Donnelly SC, McDonald K, Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 2007 115 888 895. doi: 10.1161/CIRCULATIONAHA.106.638569.
5. Mascherbauer J, Marzluf BA, Tufaro C, Pfaffenberger S, Graf A, Wexberg P, Panzenböck A, Jakowitsch J, Bangert C, Laimer D, Schreiber C, Karakus G, Hülsmann M, Pacher R, Lang IM, Maurer G, Bonderman D, Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction. Circ Cardiovasc Imaging 2013 6 1056 1065. doi: 10.1161/CIRCIMAGING.113.000633.
6. Kammerlander AA, Marzluf BA, Zotter-Tufaro C, Aschauer S, Duca F, Bachmann A, Knechtelsdorfer K, Wiesinger M, Pfaffenberger S, Greiser A, Lang IM, Bonderman D, Mascherbauer J, T1 mapping by CMR Imaging: from histological validation to clinical implication. JACC Cardiovasc Imaging 2016 9 14 23. doi: 10.1016/j.jcmg.2015.11.002.
7. White SK, Sado DM, Fontana M, Banypersad SM, Maestrini V, Flett AS, Piechnik SK, Robson MD, Hausenloy DJ, Sheikh AM, Hawkins PN, Moon JC, T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. JACC Cardiovasc Imaging 2013 6 955 962. doi: 10.1016/j.jcmg.2013.01.011.
8. Bull S, White SK, Piechnik SK, Flett AS, Ferreira VM, Loudon M, Francis JM, Karamitsos TD, Prendergast BD, Robson MD, Neubauer S, Moon JC, Myerson SG, Human non-contrast T1 values and correlation with histology in diffuse fibrosis. Heart 2013 99 932 937. doi: 10.1136/heartjnl-2012-303052.
9. Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, Gatehouse PD, Arai AE, Friedrich MG, Neubauer S, Schulz-Menger J, Schelbert EB, Society for Cardiovascular Magnetic Resonance Imaging; Cardiovascular Magnetic Resonance Working Group of the European Society of Cardiology Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 2013 15 92. doi: 10.1186/1532-429X-15-92.
10. Wong TC, Piehler K, Meier CG, Testa SM, Klock AM, Aneizi AA, Shakesprere J, Kellman P, Shroff SG, Schwartzman DS, Mulukutla SR, Simon MA, Schelbert EB, Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-Term mortality. Circulation 2012 126 1206 1216. doi: 10.1161/CIRCULATIONAHA.111.089409.
11. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL, American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013 128 1810 1852. doi: 10.1161/CIR.0b013e31829e8807.
12. Paulus WJ, Tschöpe C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, Borbély A, Edes I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL, How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007 28 2539 2550. doi: 10.1093/eurheartj/ehm037.
13. Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, Wechalekar AD, Berk JL, Quarta CC, Grogan M, Lachmann HJ, Bokhari S, Castano A, Dorbala S, Johnson GB, Glaudemans AW, Rezk T, Fontana M, Palladini G, Milani P, Guidalotti PL, Flatman K, Lane T, Vonberg FW, Whelan CJ, Moon JC, Ruberg FL, Miller EJ, Hutt DF, Hazenberg BP, Rapezzi C, Hawkins PN, Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 2016 133 2404 2412. doi: 10.1161/CIRCULATIONAHA.116.021612.
14. Bonderman D, Agis H, Kain R, Mascherbauer J, Amyloid in the heart: an under-recognized threat at the interface of cardiology, haematology, and pathology. Eur Heart J Cardiovasc Imaging 2016 17 978 980. doi: 10.1093/ehjci/jew130.
15. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon S, Spencer KT, St John Sutton M, Stewart W, American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology Recommendations for chamber quantification. Eur J Echocardiogr 2006 7 79 108. doi: 10.1016/j.euje.2005.12.014.
16. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E, Society for Cardiovascular Magnetic Resonance Board of Trustees Task Force on Standardized Protocols Standardized cardiovascular magnetic resonance Imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson 2008 10 35. doi: 10.1186/1532-429X-10-35.
17. Bondarenko O, Beek AM, Hofman MB, Kühl HP, Twisk JW, van Dockum WG, Visser CA, van Rossum AC, Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. J Cardiovasc Magn Reson 2005 7 481 485
18. Kellman P, Wilson JR, Xue H, Ugander M, Arai AE, Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method. J Cardiovasc Magn Reson 2012 14 63. doi: 10.1186/1532-429X-14-63.
19. Garvey W, Fathi A, Bigelow F, Carpenter B, Jimenez C, A combined elastic, fibrin and collagen stain. Stain Technol 1987 62 365 368
20. Shah AM, Solomon SD, Phenotypic and pathophysiological heterogeneity in heart failure with preserved ejection fraction. Eur Heart J 2012 33 1716 1717. doi: 10.1093/eurheartj/ehs124.
21. Tribouilloy C, Rusinaru D, Mahjoub H, Soulière V, Lévy F, Peltier M, Slama M, Massy Z, Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study. Eur Heart J 2008 29 339 347. doi: 10.1093/eurheartj/ehm554.
22. Persson H, Lonn E, Edner M, Baruch L, Lang CC, Morton JJ, Ostergren J, McKelvie RS, Investigators of the CHARM Echocardiographic Substudy-CHARMES Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence: results from the CHARM Echocardiographic Substudy-CHARMES. J Am Coll Cardiol 2007 49 687 694. doi: 10.1016/j.jacc.2006.08.062.
23. Zile MR, Gottdiener JS, Hetzel SJ, McMurray JJ, Komajda M, McKelvie R, Baicu CF, Massie BM, Carson PE, I-PRESERVE Investigators Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation 2011 124 2491 2501. doi: 10.1161/CIRCULATIONAHA.110.011031.
24. Mascherbauer J, Grünig E, Halank M, Hohenforst-Schmidt W, Kammerlander AA, Pretsch I, Steringer-Mascherbauer R, Ulrich S, Lang IM, Wargenau M, Frey R, Bonderman D, Evaluation of the pharmacodynamic effects of riociguat in subjects with pulmonary hypertension and heart failure with preserved ejection fraction. Wiener Klinische Wochenschrift 2016 1 8. doi: 10.1007/s00508-016-1068-8
25. Wong TC, Piehler KM, Kang IA, Kadakkal A, Kellman P, Schwartzman DS, Mulukutla SR, Simon MA, Shroff SG, Kuller LH, Schelbert EB, Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J 2014 35 657 664. doi: 10.1093/eurheartj/eht193.
26. Schelbert EB, Piehler KM, Zareba KM, Moon JC, Ugander M, Messroghli DR, Valeti US, Chang CC, Shroff SG, Diez J, Miller CA, Schmitt M, Kellman P, Butler J, Gheorghiade M, Wong TC, Myocardial fibrosis quantified by extracellular volume is associated with subsequent hospitalization for heart failure, death, or both across the spectrum of ejection fraction and heart failure stage. J Am Heart Assoc 2015 4 e002613. doi: 10.1161/JAHA.115.002613
27. Ghosn MG, Pickett S, Brunner G, Nabi F, Zoghbi W, Quinones M, Nambi V, Shah D, Association of myocardial extracellular volume and clinical outcome: a cardiac magnetic resonance study. J Am Coll Cardiol 2015 65 A1077
28. Puntmann VO, Carr-White G, Jabbour A, Yu CY, Gebker R, Kelle S, Hinojar R, Doltra A, Varma N, Child N, Rogers T, Suna G, Arroyo Ucar E, Goodman B, Khan S, Dabir D, Herrmann E, Zeiher AM, Nagel E, International T1 Multicentre CMR Outcome Study T1-mapping and outcome in nonischemic cardiomyopathy: all-cause mortality and heart failure. JACC Cardiovasc Imaging 2016 9 40 50. doi: 10.1016/j.jcmg.2015.12.001.
29. Goliasch G, Zotter-Tufaro C, Aschauer S, Duca F, Koell B, Kammerlander AA, Ristl R, Lang IM, Maurer G, Mascherbauer J, Bonderman D, Outcome in heart failure with preserved ejection fraction: the role of myocardial structure and right ventricular performance. PLoS One 2015 10 e0134479. doi: 10.1371/journal.pone.0134479.
30. Aschauer S, Kammerlander AA, Zotter-Tufaro C, Ristl R, Pfaffenberger S, Bachmann A, Duca F, Marzluf BA, Bonderman D, Mascherbauer J, The right heart in heart failure with preserved ejection fraction: insights from cardiac magnetic resonance Imaging and invasive haemodynamics. Eur J Heart Fail 2016 18 71 80. doi: 10.1002/ejhf.418.
31. Zotter-Tufaro C, Mascherbauer J, Duca F, Koell B, Aschauer S, Kammerlander AA, Panzenboeck A, Sadushi-Kolici R, Bangert C, Laimer D, Ristl R, Lang IM, Bonderman D, Prognostic significance and determinants of the 6-min walk test in patients with heart failure and preserved ejection fraction. JACC Heart Fail 2015 3 459 466. doi: 10.1016/j.jchf.2015.01.010.
32. Dalos D, Mascherbauer J, Zotter-Tufaro C, Duca F, Kammerlander AA, Aschauer S, Bonderman D, Functional status, pulmonary artery pressure, and clinical outcomes in heart failure with preserved ejection fraction. J Am Coll Cardiol 2016 68 189 199. doi: 10.1016/j.jacc.2016.04.052.
33. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, McGregor C, Moon JC, Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 2010 122 138 144. doi: 10.1161/CIRCULATIONAHA.109.930636.
34. Fontana M, White SK, Banypersad SM, Sado DM, Maestrini V, Flett AS, Piechnik SK, Neubauer S, Roberts N, Moon JC, Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR. J Cardiovasc Magn Reson 2012 14 88. doi: 10.1186/1532-429X-14-88.
35. Miller CA, Naish JH, Bishop P, Coutts G, Clark D, Zhao S, Ray SG, Yonan N, Williams SG, Flett AS, Moon JC, Greiser A, Parker GJ, Schmitt M, Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging 2013 6 373 383. doi: 10.1161/CIRCIMAGING.112.000192.
36. Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ, Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 2008 52 1574 1580. doi: 10.1016/j.jacc.2008.06.049.
37. Iles LM, Ellims AH, Llewellyn H, Hare JL, Kaye DM, McLean CA, Taylor AJ, Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis. Eur Heart J Cardiovasc Imaging 2015 16 14 22. doi: 10.1093/ehjci/jeu182.
38. aus dem Siepen F, Buss SJ, Messroghli D, Andre F, Lossnitzer D, Seitz S, Keller M, Schnabel PA, Giannitsis E, Korosoglou G, Katus HA, Steen H, T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. Eur Heart J Cardiovasc Imaging 2015 16 210 216. doi: 10.1093/ehjci/jeu183.